Síndrome da Isquemia Aguda Cutânea e/ou de Extremidades: O Que o Reumatologista Precisa Saber

2021 ◽  
Vol 5 (1) ◽  
pp. 55-59
Author(s):  
Mittermayer B. Santiago ◽  
Adriane Paz
Keyword(s):  
Ischemic Syndrome

Isquemia aguda cutânea e/ou de extremidades é uma condição não rara na prática clínica e pode ser uma manifestação de diversas doenças subjacentes ou ainda ser um fenômeno clínico cuja etiologia pode não ser definida, mesmo após uma ampla investigação complementar. Denominamos este evento de APCIS, sigla que em inglês significa ”Acute Peripheral and/or Cutaneous Ischemic Syndrome”, descrevemos alguns casos ilustrativos dessa condição e discutimos os prováveis mecanismos etiopatogênicos, destacando as situações de interesse especial para o reumatologista. Além disso, propomos uma estratégia de investigação diagnóstica e uma conduta terapêutica inicial de utilidade para médicos em geral.

Clinical features of ocular ischemic syndrome in atherosclerotic lesions of the internal carotid artery

2018 ◽  
Vol 16 (5) ◽  
pp. 173-178
Author(s):  
V. V. Tuzlaev ◽  
◽  
V. V. Egorov ◽  
I. Z. Kravchenko ◽  
G. P. Smoliakova ◽  
...  
Keyword(s):  
Carotid Artery ◽  
Internal Carotid Artery ◽  
Clinical Features ◽  
Internal Carotid ◽  
Ocular Ischemic Syndrome ◽  
Atherosclerotic Lesions ◽  
Ischemic Syndrome

scholarly journals Women’s Ischemic Syndrome Evaluation

Circulation ◽  
2004 ◽  
Vol 109 (6) ◽  
Author(s):  
Leslee J. Shaw ◽  
Jannet F. Lewis ◽  
Mark A. Hlatky ◽  
Willa A. Hsueh ◽  
Sheryl F. Kelsey ◽  
...  
Keyword(s):  
Ischemic Syndrome

scholarly journals Women’s Ischemic Syndrome Evaluation

Circulation ◽  
2004 ◽  
Vol 109 (6) ◽  
pp. 805-807 ◽  
Author(s):  
Noel Bairey Merz ◽  
Robert O. Bonow ◽  
George Sopko ◽  
Robert S. Balaban ◽  
Richard O. Cannon ◽  
...  
Keyword(s):  
Ischemic Syndrome

Telodiencephalic Ischemic Syndrome

1987 ◽  
Vol 44 (12) ◽  
pp. 1218-1219 ◽  
Author(s):  
R. Schiffter
Keyword(s):  
Ischemic Syndrome

scholarly journals Aflibercept as Adjunctive Treatment for Filtration Surgery in Neovascular Glaucoma

2022 ◽  
Vol 74 (1) ◽  
pp. 27-33
Author(s):  
Naris Kitnarong ◽  
Janyawassamon Kittipiriyakul ◽  
Anuwat Jiravarnsirikul
Keyword(s):  
Neovascular Glaucoma ◽  
Additional Treatment ◽  
Adjunctive Treatment ◽  
Panretinal Photocoagulation ◽  
Vein Occlusion ◽  
Corrected Visual Acuity ◽  
Intravitreal Aflibercept ◽  
The One ◽  
Ischemic Syndrome

Objective: To investigate intravitreal aflibercept (IVA) injection as an adjunctive treatment to trabeculectomy with mitomycin C (TMC) and panretinal photocoagulation (PRP) for neovascular glaucoma (NVG).Materials and Methods: PRP and IVA (2 mg/0.05 ml) injection were given, and TMC was performed within 2weeks after IVA. Additional PRP, laser suture lysis, subconjunctival 5-fluorouracil injection, and bleb needlingwere performed after TMC if indicated. Best corrected visual acuity (BCVA), intraocular pressure (IOP), surgicalcomplications, and number of anti-glaucoma medications were collected.Results: Five eyes from 5 consecutive patients were included. Two eyes had proliferative diabetic retinopathy (PDR), 2 central retinal vein occlusion, and 1 ocular ischemic syndrome (OIS) (mean initial IOP: 46.8±6.8 mmHg). NVI regression occurred in one eye after PRP alone, and in one eye after PRP and IVA resulting in a good IOP control with topical medical therapy. The other 3 underwent TMC. The preoperative IOP was 34 (OIS), 54 (PDR), and 50 (PDR) mmHg. The 3-month postoperative IOP decreased to 8, 8, and 4 mmHg, respectively, and to 21, 10, and 6 mmHg, respectively, at the last visit. Only the one OIS eye required postoperative topical IOP-lowering medications. Final BCVA was improved, unchanged, and decreased in 2, 2, and 1 eye, respectively. No intraoperative/postoperative complications or NVI recurrence were observed (mean follow-up: 10.7 months).Conclusion: Intravitreal aflibercept was shown to be a potentially effective additional treatment to PRP and TMC in patients with NVG.

Sign in / Sign up

Export Citation Format

Share Document